Ligand Pharma Sells $688K: CFO Stock Sale Spotlight
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Need immediate cash? Explore where to sell things for immediate cash and get the funds you need right away.
20,928 articlesWhen a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Costco crossed the $1,000 mark in early May 2026, prompting fresh debate about selling in May—even for blue-chip equi...
As 2025 closed, bank-owned homes grew rapidly, reshaping costs, timelines, and opportunities for buyers and investors...
A major shift in ServiceNow's strategy, led by aggressive AI integration and larger enterprise contracts, could set t...
A landmark decision reshapes the Fed’s usual leadership path. This article breaks down what happened, why it matters ...
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
The first half of the year brought a sharp move for ServiceNow as AI expectations collided with reality. This article...
As earnings season unfolds, Apogee faces a meaningful year ahead. This article breaks down Q1 signals, outlines a rea...
Palo Alto Networks is set to report fiscal Q3 after the close, with investors eyes on growth guidance and the CyberAr...
In a market obsessed with the next AI breakthrough, one stock stands out not for hype but for real, lasting traction....
After a prolonged rally, the AI-heavy trade just worst stretch put gains on pause. This article outlines three clear ...
Netflix faces a shifting market environment even as its ad-supported push gains momentum. This piece weighs the buy, ...